SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001016504-15-000012
Filing Date
2015-10-26
Accepted
2015-10-26 17:19:10
Documents
7
Period of Report
2015-10-26
Effectiveness Date
2015-10-26

Document Format Files

Seq Description Document Type Size
1 inbproxy2015.htm DEF 14A 451625
2 inb001.jpg GRAPHIC 35662
3 inb002.jpg GRAPHIC 55863
4 inb003.jpg GRAPHIC 54273
5 inbaaa.jpg GRAPHIC 108381
6 inbbbb.jpg GRAPHIC 79471
7 inbccc.jpg GRAPHIC 30718
  Complete submission text file 0001016504-15-000012.txt   955312
Mailing Address 225 LONG AVENUE PO BOX 278 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE PO BOX 278 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-31668 | Film No.: 151175684
SIC: 2834 Pharmaceutical Preparations